HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuyasu Terashima Selected Research

Angina Pectoris

1/2015Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound.
6/2014Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy.
4/2014Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris.
2/2014Impact on optical coherence tomographic coronary findings of fluvastatin alone versus fluvastatin + ezetimibe.
1/2013C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
9/2012Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
9/2006Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
10/2005Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease.
11/2002Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuyasu Terashima Research Topics

Disease

25Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 11/2002
17Atherosclerotic Plaque (Atheroma)
09/2016 - 08/2007
9Hyperplasia
01/2019 - 11/2005
9Angina Pectoris
01/2015 - 11/2002
7Thrombosis (Thrombus)
01/2022 - 12/2009
6Atherosclerosis
03/2015 - 11/2002
6Diabetes Mellitus
05/2014 - 02/2006
5Neointima
01/2019 - 02/2006
5Myocardial Infarction
10/2015 - 09/2006
5Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 03/2009
5Pathologic Constriction (Stenosis)
04/2012 - 11/2005
4Rupture
04/2012 - 03/2009
3Hypertension (High Blood Pressure)
09/2015 - 02/2007
3Unstable Angina
04/2013 - 10/2005
2Death (Near-Death Experience)
10/2015 - 05/2014
2Stable Angina
07/2013 - 07/2009
2Acute Coronary Syndrome
04/2013 - 12/2009
2AIDS-Related Complex (ARC)
05/2012 - 11/2005
2Coronary Vasospasm (Coronary Artery Vasospasm)
03/2012 - 02/2012
2Coronary Stenosis (Coronary Artery Stenosis)
03/2012 - 02/2012
1Chronic Renal Insufficiency
11/2016
1Acute Kidney Injury (Acute Renal Failure)
11/2016
1Hypercholesterolemia
09/2016
1Intussusception
06/2012
1Dyslipidemias (Dyslipidemia)
04/2012
1Muscle Spasticity (Spastic)
03/2012
1Prolapse
03/2012
1Spasm (Spasms)
03/2012
1Necrosis
02/2012
1Fibrosis (Cirrhosis)
02/2012
1Hypersensitivity (Allergy)
12/2009
1Flushing
03/2008
1Hyperlipidemias (Hyperlipidemia)
02/2007
1Inflammation (Inflammations)
09/2006

Drug/Important Bio-Agent (IBA)

19Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2016 - 07/2009
12Sirolimus (Rapamycin)FDA Link
05/2014 - 11/2005
9LipidsIBA
10/2018 - 07/2009
8MetalsIBA
01/2019 - 11/2005
4CalciumIBA
09/2013 - 11/2005
4NADPH Oxidases (NAD(P)H oxidase)IBA
06/2009 - 11/2002
3omega-Chloroacetophenone (Mace)IBA
10/2015 - 03/2009
3LDL CholesterolIBA
09/2015 - 07/2009
3Pravastatin (Pravachol)FDA LinkGeneric
01/2015 - 06/2013
2CholesterolIBA
09/2016 - 07/2013
2LDL Lipoproteins (beta Lipoproteins)IBA
09/2015 - 07/2009
2Amlodipine (Norvasc)FDA LinkGeneric
09/2015 - 02/2012
2pitavastatin (itavastatin)FDA Link
01/2015 - 06/2013
2FluvastatinFDA Link
02/2014 - 07/2009
2Docosahexaenoic AcidsIBA
01/2014 - 01/2013
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2013 - 01/2013
2oxidized low density lipoproteinIBA
01/2013 - 11/2002
2Phenobarbital (Luminal)FDA Link
03/2012 - 02/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2009 - 01/2007
1Pharmaceutical PreparationsIBA
01/2022
1Contrast MediaIBA
01/2016
1Atenolol (Tenormin)FDA LinkGeneric
09/2015
1pigment epithelium-derived factorIBA
03/2015
1Uric Acid (Urate)IBA
06/2014
1Lipoprotein(a)IBA
04/2014
1Ezetimibe (Zetia)FDA Link
02/2014
1Platelet Activating FactorIBA
04/2013
1Eicosapentaenoic AcidIBA
01/2013
1C-Reactive ProteinIBA
01/2013
1Arachidonic Acid (Vitamin F)IBA
01/2013
1Atorvastatin (Lipitor)FDA Link
04/2012
1Ergonovine (Ergometrine)IBA
03/2012
1Telmisartan (Micardis)FDA Link
02/2012
1Ringer's LactateIBA
03/2008
1Interleukin-6 (Interleukin 6)IBA
09/2006
1CD40 Ligand (CD40L)IBA
09/2006
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2005
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
11/2002
1Oxidoreductases (Dehydrogenase)IBA
11/2002
1Superoxides (Superoxide)IBA
11/2002
1NAD (NADH)IBA
11/2002

Therapy/Procedure

24Stents
01/2022 - 11/2005
20Therapeutics
09/2016 - 07/2009
10Percutaneous Coronary Intervention
11/2016 - 02/2006
4Drug-Eluting Stents
01/2022 - 05/2010
1Renal Dialysis (Hemodialysis)
11/2016
1Catheters
06/2012
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2009